Because of the inhibition of ovarian tumor growth and increased apoptosis in in vivo tumor specimens, we next examined the in vitro effects of Grb2 downregulation by siRNA on the ovarian cancer cell lines described above. The gene discussed is GRB2; the disease is ovarian carcinoma.